, /PRNewswire/ -- Sumitomo Corporation, through its U.S. subsidiary Sumitomo Corporation of Americas (SCOA), announced an investment in Vast Medical Holdings, which owns Quest Health Solutions (Quest).
This transaction marks Sumitomo Corporation Group's entry into the U.S. healthcare market and represents a strategic move to enhance interventions and manage the needs of chronic-care patients.
Chronic diseases, including diabetes, significantly impact the U.S. population.
According to the Centers for Disease Control and Prevention, 38.4 million people, or 11.6% of the U.
S. population, live with diabetes which is expected to rise. This number is also estimated to jump to approximately 40% of the U.
S. population when including those living with prediabetes or higher than normal blood sugar levels. Quest offers comprehensive services for diabetes care, acting as a vital link between patients, care providers, medical device manufacturers and health insurers.
Quest directly supplies Continuous Glucose Monitors (CGM) and related products to patients. Through its sister companies, Quest Health Remote Care and Quest Health RPM Services (remote patient monitoring), the company integrates CGM data with clinical support services such as patient education, meal planning, and exercise guidance to improve health outcomes. The investment by Sumitomo Corporation Group in the U.
S. healthcare market expands its network of health insurers and medical institutions, which are the foundation of its.